BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9398801)

  • 1. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.
    Möhler M; Gutzler F; Kallinowski B; Goeser T; Stremmel W
    Dig Dis Sci; 1997 Nov; 42(11):2241-5. PubMed ID: 9398801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy.
    Cavanna L; Civardi G; Fornari F; Vallisa D; Berte R; Buscarini E; Sbolli G; Paties C; Foroni R; Di Stasi M
    Acta Cytol; 1994; 38(3):451-4. PubMed ID: 8191841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection and non-Hodgkin's lymphoma: a review and case report of nine patient.
    Lizardi-Cervera J; Poo JL; Romero-Mora K; Castañeda B; Pichardo-Bahena R; Morán S; Uribe M
    Ann Hepatol; 2006; 5(4):257-62. PubMed ID: 17151577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection in non-Hodgkin's lymphoma.
    King PD; Wilkes JD; Diaz-Arias AA
    Clin Lab Haematol; 1998 Apr; 20(2):107-10. PubMed ID: 9681221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection.
    Bauzá A; España A; Lloret P
    Eur J Dermatol; 2003; 13(3):302-4. PubMed ID: 12804996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
    Haanen JB; Bieger R; van't Wout JW
    Neth J Med; 1996 Dec; 49(6):239-43. PubMed ID: 8990863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
    Page RD; Romaguera JE; Osborne B; Medeiros LJ; Rodriguez J; North L; Sanz-Rodriguez C; Cabanillas F
    Cancer; 2001 Oct; 92(8):2023-9. PubMed ID: 11596015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chylothorax resulting from malignant non Hodgkin's lymphoma].
    Ohyama S; Bando K; Hasegawa Y; Taniguti M; Shirayma H
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):473-7. PubMed ID: 9742867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Sonneveld P; de Ridder M; van der Lelie H; Nieuwenhuis K; Schouten H; Mulder A; van Reijswoud I; Hop W; Lowenberg B
    J Clin Oncol; 1995 Oct; 13(10):2530-9. PubMed ID: 7595704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment.
    Iannitto E; Ammatuna E; Tripodo C; Marino C; Calvaruso G; Florena AM; Montalto G; Franco V
    Hematol J; 2004; 5(6):530-3. PubMed ID: 15570298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
    De Renzo A; Perna F; Persico M; Notaro R; Mainolfi C; de Sio I; Ciancia G; Picardi M; Del Vecchio L; Pane F; Rotoli B
    Eur J Haematol; 2008 Jul; 81(1):51-7. PubMed ID: 18397390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary non-Hodgkin lymphoma of the liver: case report and review of the literature].
    Nasr Ben Ammar C; Chaari N; Kochbati L; Besbes M; Maalej M
    Cancer Radiother; 2006 Dec; 10(8):595-601. PubMed ID: 17137818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
    Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
    Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-dose chop therapy for elderly patients with non-Hodgkin's lymphoma.
    Mori M; Niitsu N; Takagi T; Tomiyama J; Matsue T; Nakagawa Y; Okamoto R
    Leuk Lymphoma; 2001 Apr; 41(3-4):359-66. PubMed ID: 11378549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin's lymphoma: study of 26 patients].
    Moreno M; Sancho JM; Gardella S; Coll R; García O; Gallardo D; Ribera JM
    Med Clin (Barc); 2010 Jan; 134(2):72-5. PubMed ID: 19913261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
    Shpilberg O; Shiff J; Chetrit A; Ramot B; Ben-Bassat I
    Cancer; 1994 Dec; 74(11):3029-33. PubMed ID: 7525042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.